Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and commercial organizations are VHIO’s Director Josep Tabernero and Enriqueta Felip, Principal Investigator of our Thoracic Tumors & Head and Neck Cancer Group.
Powered by Web of ScienceTM data and InCitesTM metrics provided by Clarivate, and using both quantitative and qualitative analysis, this year’s list of Highly Cited Researchers includes 6,938 individuals who have demonstrated significant and broad influence in their field(s) of research across the 22 broad disciplines used by Essential Science Indicators (ESI).
Josep Tabernero has for the seventh consecutive year been selected for significantly advancing cancer research under the category of Clinical Medicine that lists a total of 466 named leaders this year. Joining Josep is VHIO’s Enriqueta Felip who has now been recognized in this same field for a fifth year running.
“I am honored to have been included in this year’s listing of highly cited researchers. This recognition is not however about individual efforts or achievements. It is reflective of just what can be achieved through teamwork and collaboration with hugely dedicated colleagues and peers at the national and global levels,” said Josep Tabernero, Head of the Vall d’Hebron University Hospital’s (HUVH) Medical Oncology Department.
“I take this opportunity to recognize and thank all of our translational teams and talents, research partners, and other specialties who co-drive advances against cancer. Only together will we succeed in more effectively combating this devastating disease,” added Enriqueta Felip, Head of the Thoracic Cancer Unit at HUVH and President of the Spanish Society of Medical Oncology (SEOM).
On behalf of all at VHIO, we congratulate Josep and Enriqueta for this important recognition and applaud their outstanding contributions to cancer science and medicine.
To access the 2022 list of Highly Cited Researchers please click here.
